Camber debuts generic Aubagio
Teriflunomide tablets are indicated for treating relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease in adults.
Camber is introducing teriflunomide tablets, which are the generic of Aubagio.
Teriflunomide tablets are indicated for the treatment of relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease in adults.
[Read more: Camber intros generic Ranexa]
Teriflunomide tablets are available in 7 mg and 14 mg and are supplied in 30-ct. bottles.
[Read more: Camber launches generic Valcyte]